BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• 

  Business

  Gilead’s $600 Million NASH Deal Finally Bears Fruit

  April 24, 2017

   · 

  3 min read
• BioCapital

  The Scariest Prescription Drug Price Chart You’ll Ever See

  April 24, 2017

   · 

  1 min read
• Drug Development

  Alder Biopharma Presents Additional Data From Eptinezumab Development Program At 69th Annual American Academy of Neurology Meeting

  April 24, 2017

   · 

  5 min read
• BioCapital

  Alvogen To Market Regenerative Fish Skin In Korea, Taiwan And Thailand

  April 24, 2017

   · 

  3 min read
• Deals

  Becton, Dickinson and Company Snaps Up C.R. Bard in $24 Billion Deal

  April 24, 2017

   · 

  16 min read
• Drug Development

  Eli Lilly Finally Catches A Break With Encouraging Phase III Breast Cancer Data

  April 24, 2017

   · 

  7 min read
• Drug Development

  Inovio Pharma Initiates Phase II Efficacy Trial With VGX-3100 For HPV-Related Vulvar Pre-Cancers

  April 24, 2017

   · 

  7 min read
• Business

  Amgen Announces Webcast Of 2017 First Quarter Financial Results

  April 24, 2017

   · 

  1 min read
• Drug Development

  aTyr Pharma Presents Analyses Of Resolaris Phase Ib/II Trial In Patients With Limb Girdle Muscular Dystrophy 2B And Facioscapulohumeral Muscular Dystrophy At The American Academy of Neurology 69th Annual Meeting

  April 24, 2017

   · 

  5 min read
• Drug Development

  aTyr Pharma Announces Promising Top-Line Results From Resolaris Phase Ib/II Clinical Trial In Patients With Early Onset Facioscapulohumeral Muscular Dystrophy

  April 24, 2017

   · 

  6 min read